IndusInd Bank's Shrinking CASA Ratio Signals a Margin and Growth Squeeze as Institutional Risk Premium Widens

The recent data from IndusInd Bank paints a picture of a bank retreating from the balance sheet, not expanding it. In the quarter ended March 31, net advances declined 5.2 percent quarter-on-quarter to ₹3.47 lakh crore, while total deposits grew a mere 0.4 percent sequentially. This is not a strategic asset build; it is a defensive funding squeeze. The bank is holding onto cash on its balance sheet rather than deploying it into loans, a move that pressures earnings and raises questions about its competitive positioning.

The cost of this defensive stance is visible in the bank's funding mix. The Current Account Savings Account (CASA) ratio fell to 32.8 percent, a significant decline from 37.9 percent a year ago and 34.9 percent in the prior quarter. A lower CASA ratio directly drags on net interest margins, as it means a larger portion of deposits are from higher-cost sources like term deposits. This is a key quality factor for private banks, and IndusInd's deterioration here is a red flag for risk-adjusted returns.

This defensive posture stands in stark contrast to a broader sector trend. While IndusInd contracted, some peers are regaining lending momentum. The bank's own consumer banking segment saw net advances expand 3.4 percent quarter-on-quarter, but that growth was more than offset by a 15.1 percent quarterly contraction in corporate banking.

This divergence suggests IndusInd is not merely navigating cyclical headwinds but may be underperforming in its core lending businesses. In a sector rotation context, where capital is flowing toward banks demonstrating stronger asset growth and more stable funding, this defensive, costly strategy makes IndusInd a potential underweight candidate. The move is a liquidity buffer, but it comes at the expense of margin quality and relative growth.

Financial Health and the Quality Factor Test

The bank's balance sheet strength is a study in contrasts. On one hand, it maintains a robust capital cushion. The bank's capital adequacy ratio stands at 16.24% after absorbing all the impact of recent irregularities, providing a tangible buffer against future shocks. Liquidity is also healthy, with an average LCR of 118% and excess liquidity of ₹39,600 crore. This is a defensive quality metric, ensuring solvency, but it does not signal operational strength or growth potential. The more telling quality factor is the market's verdict. The stock has fallen 49 per cent in the past six months, a deep de-rating that reflects institutional skepticism about governance and future earnings quality. This isn't a simple cyclical dip; it's a fundamental reassessment of risk. The market is pricing in a higher risk premium for the bank's stock, which directly impacts its cost of equity and makes it a less attractive holding for portfolios seeking stable, high-quality returns.

The tension between a solid balance sheet and a devalued equity is the core institutional dilemma. The bank's capital and liquidity are intact, but the erosion of trust has severely damaged its market capitalization. For a portfolio manager, this creates a bifurcated view: the bank is not a credit risk, but it is a governance and earnings quality risk. The recent leadership transition, with the board working to appoint a new CEO, is a necessary step toward restoring the quality factor, but it is a process that will take time. Until then, the stock's depressed valuation may offer a speculative entry, but it does not yet meet the criteria for a conviction buy on quality grounds.

Valuation and the Institutional Risk Premium

The market's verdict on IndusInd Bank is clear and severe. The stock trades at a Price-to-Earnings ratio of 7.26, a deep discount to the industry average of 12.72. This gap is not a simple valuation quirk; it is the institutional risk premium in real time, pricing in high perceived risk from governance issues to operational headwinds. For a portfolio manager, this discount signals that the market is not rewarding the bank's solid capital and liquidity buffers. Instead, it is demanding a higher return for bearing the specific risks of this name.

Global broker UBS crystallizes this institutional skepticism. The firm maintains a 'Sell' rating and has sharply cut its price target to ₹600, implying a potential downside of 15 percent. UBS's rationale is structural, citing deposit flows, the CEO transition, and audit findings as key risk factors. The brokerage has also revised its growth outlook downward, cutting loan growth estimates and trimming earnings projections by 14-15% for the next two years. This is a top-down downgrade that aligns with the stock's performance, which has fallen about 55 percent from its recent high.

The trading profile reinforces this cautious institutional view. With an average daily trading volume of 2.48 million shares, there is a moderate institutional flow presence, but not the kind of strong conviction buy signal that would suggest a rotation into the stock. The volume is sufficient for liquidity but does not indicate a surge of capital seeking a quality turnaround. The stock's recent 3% drop on April 4, following UBS's target cut, shows that negative catalysts can quickly move the price despite the deep discount.

The bottom line is one of bifurcated risk. The valuation offers a margin of safety, but the risk premium is not for credit or liquidity. It is for execution and governance. Until the bank demonstrates a clear, credible path to reversing the deposit outflow, stabilizing its funding mix, and delivering on its revised growth targets, the institutional risk premium will remain elevated. For now, the market is not rewarding quality; it is pricing in uncertainty.

Catalysts, Risks, and Portfolio Implications

For portfolio managers, the path forward hinges on a few specific catalysts and risks. The current institutional skepticism, crystallized by UBS's sharp price target cut, will only be reversed if the bank demonstrates a credible resolution to its core governance and operational issues. The primary catalyst for a re-rating is the resolution of the external auditor's report findings. UBS explicitly views these findings as critical indicators for the bank's future performance. Until the bank provides clarity and assurance on these matters, the elevated risk premium will persist, limiting any meaningful valuation recovery.

For a portfolio overweight to be justified, the bank must show a fundamental improvement in its funding and growth profile. The key metrics to watch are sequential deposit growth acceleration and a stabilization in the CASA ratio. The recent quarter's 0.4 percent sequential deposit growth and declining CASA ratio signal a costly, defensive funding base. A reversal of this trend-specifically, a return to steady deposit inflows and a rebound in the CASA ratio toward historical levels-would be required to signal a less expensive funding base and a return to operational normalcy. This would directly support the bank's net interest margin and earnings trajectory.

The key risk to any conviction is further deterioration in asset quality or a failure to regain lending momentum. UBS has already trimmed earnings estimates by 14-15% for the next two years, citing elevated credit costs of approximately 1.7 percent in FY26 and a cut to loan growth estimates. If credit costs remain high or net advances continue to contract, it would pressure the already low valuation multiple and justify a sector rotation away from the stock. The bank's 15.1 percent quarterly contraction in corporate banking advances is a red flag that must be addressed.

In practice, the institutional view remains cautious. The stock's recent 3% drop on April 4, following UBS's target cut, shows that negative catalysts can quickly move the price. With a moderate average daily trading volume, there is no strong institutional flow signaling a rotation into the stock. The bottom line is that the current setup demands a wait-and-see approach. Until the bank provides clarity on the audit findings and demonstrates a clear, sustainable path to stabilizing deposits and improving its funding mix, the stock remains a high-risk, low-conviction holding.